PETALUMA, Calif., May 10, 2011 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today provided a business update in advance of the company’s June 2, 2011 earnings release and conference call.
